chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left knee pain.  Symptoms reported on November 27 around noon, hurts to walk.  Needed to be carried because of pain even with taking tylenol and motrin.  Doctor examined on December 3, said knee was stable, recommended rest and ice, if continues will do an x-ray.  Did x-ray on December 10, results were reported as normal.  Family received results on December 13, referred to Bone and Joint for exam, possible physical therapy, first visit December 17.  Pain seems to come and go, still requires tylenol or motrin from time to time, walks with a limp.
Dizziness, double vision, numbness in the arms and legs, tingling in the hands and feet. Muscle weakness, vomiting and difficulty walking.
Approximately 8 minutes post vax, the patient's mother noted a rash on the upper part of the patient's face. The rash appeared as red pinpoint dots. There was no rash noted on any other body parts. The patient was advised to seek medical attention.
DAY 8 AFTER INJECTION- ITCHY, RED, SMALL WELT AT INJECTION SITE DAY 9-INCREASED SIZE OF REDNESS, WARM TO TOUCH, TENDER DAY 10- INCREASED AREA OF REDNESS, HOT TO TOUCH, MORE TENDER
COVID-19 I tested July 15, 2022  experienced cough, fatigue, hoarse throat. I was prescribed Paxlovid for my symptoms.
Pt developed redness, heat and slight swelling on right arm, where pneumococcal vaccine was given. Ice applied X 1.
Received all five Moderna covid vaccines, alternated arms. The first one caused pain and swelling of lymph nodes under left arm . Pain/discomfort has lasted since first vaccine and each booster  aggravates it. Have seen my gynecologist, and my md. Have had diagnostic mammograms and ultrasounds.
This case was reported by a healthcare professional and described the occurrence of cellulitis in a 18-month-old male subject who was vaccinated with Infanrix (GlaxoSmithKline) for prophylaxis. Concurrent vaccination included Havrix given in the right thigh on 22 September 2007. On 22 September 2007 the subject received 4th dose of Infanrix at 0.5 ml, intramuscularly, in the left thigh. Other vaccinations given the same day included Havrix given intramuscularly in the right thigh. On 23 September 2007, 1 day after vaccination with Infanrix, the subject experienced cellulitis. He was taken to the emergency room. The physician observed an area that was eight by eight centimeters, round and raised. This case was assessed as medically serious. The subject was treated with Rocephin. At the time of reporting the event was unresolved. The healthcare professional considered the event was probably related to vaccination with Infanrix. Follow-up information received on 16 October 2007 indicated that the subject was diagnosed with an allergic reaction which was resolved at the time of reporting. The outcome of the cellulitis was not specifically reported. In the reporter's opinion, the events were related to treatment with Infanrix. The reporter stated that in the future, Infanrix will be administered on a separate visit than other vaccines.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On unknown dates the patients was vaccinated with improperly stored (Merck) VARIVAX (lot # L035124, expiration date 14-SEP-2017, dose and route not reported). It was reported that the vaccine was improperly stored at 15.1 F for 18 hours. Digital data logger (DDL) was used to capture this temperature excursion. No adverse effects reported. This is one of several reports received from the same source. Additional information is not expected because we are not allowed to contact the physician.
flu symptoms; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA (flu symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (flu symptoms). At the time of the report, INFLUENZA (flu symptoms) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were provided.   This case was linked to MOD-2022-561892, MOD-2022-561887 (Patient Link).
This spontaneous report as received from a consumer (patient's daughter), refers to a 89 year old male patient with none pertinent medical history. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot # not reported) (dose and route not reported). Concomitant therapy was not reported. The patient's daughter reported that her father experienced on an unknown date, about two years after being vaccinated with ZOSTAVAX, "shingles, big swollen blisters, a red line from the back of the head down the side of the face, nerve pain, tingling, weakness, and a stroke." The patient's daughter stated her father was "treated with a gel type substance (unspecified name, dosage/frequency, and manufacturer) for the shingles in the eye, and a prescription (unspecified name, dosage/frequency, and manufacturer) for nerve pain." The patient was also taking an unspecified blood pressure medication prescribed for prevention of a second stroke, not prescribed for high blood pressure (also reported as a concomitant therapy). The reporter stated, "she did not think her father's stroke was related to receiving ZOSTAVAX. At the time of the report the patient's outcome was recovering. Upon internal review the stroke was considered other important medical event. Additional information has been requested.
After taking the vaccine, inside my nose start to boil something like acne. It has never gone away. I feel infection inside my nose. I was thinking maybe because of food but it's not related to food or weather. I never had an allergic reaction in my life. My nose never had something like this and now my ear is the same. I feel infection inside my ear exactly like my nose.
This spontaneous report was received from an unspecified reporter via an online article published and Vaccine Adverse Event Reporting System and refers to a 1394 patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with doses of quadrivalent HPV vaccine (manufacturer unknown) (route, dose, lot # and expiration date not reported). On unknown dates, the patients experienced a disabling adverse event. The outcome of adverse event was unknown. The relatedness between the event and quadrivalent HPV vaccine (manufacturer unknown) was not reported. This is one of several reports received from the same reporter. Additional information is not expected as no contact details were provided.
Wakes up with high pitched screaming and crying. Only sleeps 2 hours a night. Won't go to sleep on her own, she has to be rocked to sleep and this takes anywhere from 1 hour to 3 hours. Per doc no 197989, annual follow up: patient still has sleeping problems. She is somewhat better but no the way she was before the shots.
BLOOD CLOTS IN FEMORAL OF RIGHT LEG; This spontaneous report received from a patient concerned a 68 year old female of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: postmenopause, and other pre-existing medical conditions included: The patient never had past issues with clots. The patient was not pregnant at the time of vaccination. The patient previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 206A21A or 206AZ1A, expiry: unknown) dose was not reported, 1 total administered on 21-MAY-2021 for covid-19 prophylaxis.  It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (Dose number in series 1).  The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855835, expiry: unknown) dose was not reported, 1 total administered on 03-DEC-2021 for covid-19 prophylaxis. Age at time of vaccination 68 years old. No concomitant medications were reported.  On 01-MAR-2022, the patient experienced blood clots in femoral of right leg, and was hospitalized (date unspecified) (Dose number in series 2). On the same day, the patient had 2 emergency surgeries (had emergency room visit). On 02-MAR-2022, the next day, the patient underwent 1 additional emergency surgery. Patient had 3 emergency surgeries due to blood clots in femoral of right leg. Patient had the 4th surgery scheduled on 10-MAR-2022 (next Tuesday). The number of days of hospitalization was reported as 16. The patient was on blood thinner apixaban (Eliquis) since surgery. The patient stated she was upset and life was going down hill.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blood clots in femoral of right leg. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20230126072- blood clots in femoral of right leg.. The event has a compatible/suggestive temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event. Therefore, this event is considered consistent with vaccine administration.
Vaccine was administered to right shoulder on the 30th of May. On the 6-7th of June, redness and slight swelling began to occur on the right bicep and right armpit area. On the 8th the local hospital administered antibiotics intravenously and symptoms began to decrease the following 1-2 days with antihistamines. Other symptoms itching (localized) and pain in the armpit region.
got hives all over her arms, chest and neck.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 61-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 06Nov2023 at 11:00 as dose 1, single (Lot number: HG5967) at the age of 61 years for covid-19 immunisation. The patient's relevant medical history included: "help her sleep" (unspecified if ongoing), notes: taking a bunch of medicine to help her sleep. The patient's concomitant medications were not reported. Vaccination history included: comirnaty (DOSE 1, single, Lot number: EH9899, Anatomical Site: left arm), administration date: 18Dec2020, when the patient was 58-year-old, for covid-19 immunisation, reaction(s): "without any problems"; comirnaty (DOSE 2, single, Lot number: EK9231, Anatomical Site: left arm), administration date: 08Jan2021, when the patient was 58-year-old, for covid-19 immunisation, reaction(s): "without any problems"; comirnaty (DOSE 3, single, Lot number: FF2590, Anatomical Site: left arm), administration date: 06Oct2021, when the patient was 59-year-old, for covid-19 immunisation, reaction(s): "without any problems"; comirnaty original/omicron ba.4-5 (DOSE 4, single, Lot number: GH9693, Anatomical Site: left arm), administration date: 13Oct2022, when the patient was 60-year-old, for covid-19 immunisation, reaction(s): "without any problems"; Flu vaccine (definitely not within 4 weeks of booster), for immunisation. The following information was reported: URTICARIA (medically significant) with onset 06Nov2023 at 12:00, outcome "not recovered", described as "got hives all over her arms, chest and neck.". The events "got hives all over her arms, chest and neck." required emergency room visit. Therapeutic measures were taken as a result of urticaria. Clinical course: Patient clarified that last one (refers to dose 4) was 13Oct2022, she just figured that it would be good thing because she works in hospital. So many people come in with Covid, thought she should get booster. Because she works at hospital, they make sure she has flu vaccination, was definitely not within 4 weeks of booster. Patient has had other Pfizer vaccinations without any problems. This time, she got Pfizer Covid-19 booster at 11AM on 06Nov2023 and noticed hives within the hour (also reported as about hour after shot at 11AM), she had really bad reaction: got hives all over her arms, chest and neck. Patient had to go to emergency room (clarified admission to hospital was not involved), everyone at the emergency room asked what was happening to her neck, was scratching like crazy. They (HCPs) prescribed her Prednisone 60mg per day for 5 days. Aside from the Prednisone, she has been taking BENADRYL. As soon as she came off it, the hives came back but not as severe. She is still getting hives. The events "got hives all over her arms, chest and neck." required emergency room visit. Therapeutic measures were taken as a result of urticaria. Outcome of the event was not recovered.
get sick; Initial information received on 20-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer (patient) via social media.  This case involves a patient (unknown demographics) who got sick (illness), when received INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer batch number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient got sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported that he/she will not get the flu vaccine because he/she  get sick from the flu shot, yes and do have problems with the flu vaccine. Every year that patient don't get the flu shot, don't get sick and every year when the patient gets the flu vaccine gets sick.  Laboratory details were not reported.   It was not reported if the patient received a corrective treatment.  The event outcome was unknown for illness.  There will be no information available on the batch number for this case.
There is a swelling in certain part of armpit and outside of the arm, there are like 4 fingers, like 4 fingers tentatively swelling on her arms; I have a swelling in my armpit the size of a golf ball; There is a swelling in certain part of armpit and outside of the arm, there are like 4 fingers, like 4 fingers tentatively swelling on her arms; I have a swelling in my armpit the size of a golf ball; This is a spontaneous report from a contactable consumer (Patient) via a Pfizer sponsored program. A contactable 66-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0176 and Expiration Date was not reported) via an unspecified route of administration, administered in left arm on 22Jul2021 at 12:00 (age at vaccination was 66-Years-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient's medical history and Concomitant medication(s) were not reported. It was reported that there was a swelling in certain part of armpit and outside of the arm, there were like 4 fingers, like 4 fingers tentatively swelling on her arms. So, she wanted to know if its normal and the caller stated that she received the vaccination card but unfortunately she had no appointment for the second dose scheduled. She didn't understand she have a swelling in her armpit the size of a golf ball. Patient did not receive any treatment for the events. Outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
Day after shots given, pt developed rash and was admitted for further evaluation. Pt also had an ear infection and was on Zithromax. Pt final dx was HSP. 4/14/08-records received for DOS 4/3/08-presented to ED with ras one day after vaccination.  Rash consistent with erythema multiforme with hemorrhagic features. Petchial and purprua. PE: erythematous rash. DX HSP.
Mother states when client woke up 7/29/09 @ 8:30 AM, the back of her (L) arm was red with rash + swollen the size of 1/2 dollar.  Reports putting cold compress to area.  States AM of 7/30/09, client's (L) arm (back of arm) is red, hot to touch, + swollen the size of a fist.
Diagnosed with multiple pulmonary emboli after presenting  to ED with pleuritic chest pain and DOE. Unclear time of onset of symptoms, possibly preceding 2nd dose of vaccine by about 1 month. unclear temporal relation to initial vaccine dose.
This is a spontaneous report from a contactable consumer by way of Claim letter. A male patient of an unknown age and race received PREVNAR 13 injection on 22Dec2016 for an unknown indication. The dose, frequency and route of administration were unknown. The relevant medical history, concomitant medications and past drug history were unknown. It was reported that since he received his pneumonia injection, he had unspecified urinary incontinence and sweating. The relevant lab data was unknown. The action taken with pneumococcal 13-val conj vac (dipht crm197 protein) in response to the event was unknown. The therapeutic measures taken were unknown. As of 11Jul2017, the clinical outcome of the events unspecified urinary incontinence and sweating was unknown.
fever (99-102), body aches, joint pain, lethargy, chills, eye pain, headache, loss of appetite
This case was reported by a nurse via sales rep and described the occurrence of slow response to stimuli in a 59-year-old male patient who received SHINGRIX for prophylaxis. Co-suspect products included BOOSTRIX for prophylaxis. The patient's past medical history included shingles. On 13th March 2019, the patient received the 1st dose of SHINGRIX and the 1st dose of BOOSTRIX. On 13th March 2019, less than a day after receiving SHINGRIX and BOOSTRIX, the patient experienced slow response to stimuli, itching both hands, lip swelling, numbness facial and numb lips. On 16th March 2019, the outcome of the slow response to stimuli, itching both hands, lip swelling, numbness facial and numb lips were recovered/resolved. It was unknown if the reporter considered the slow response to stimuli, itching both hands, lip swelling, numbness facial and numb lips to be related to SHINGRIX and BOOSTRIX. Additional details were provided as follows: The reporter provided limited information.
7/19/05 Presented with itchy rash last night. Exposed to varicella 2 weeks ago. History of varicella 7/16/02. Diagnosed with varicella.
soreness at reaction site/ It was red/swollen; soreness at reaction site/ It was red/swollen; soreness at reaction site/ It was red/swollen; This is a spontaneous report from a contactable consumer.  A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date as first single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced soreness at reaction site/ it was red/swollen on an unspecified date. Clinical details  were as follows:  After the 1st dose of the vaccine, the patient experienced soreness at reaction site only for 1-2 days then it went away; It was red and swollen. The patient kept rubbing it, and said that it was no big deal. The outcome of soreness at reaction site/ it was red/swollen was unknown.   The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up .
Left arm became red, hot to touch and raise area formed at injection site size of baseball. Did not run a fever. Symptoms disappeared in 5 days.
Itchy mouth and tongue 15 minutes after shot. Told nurse and saw Doctor. Waited additional 45 minutes. No other side effect.
Patient developed diarrhea which started the day after vaccination and lasted for 4 days, multiple stools a day   Infant was exclusively breastfeeding.   Stool studies revealed a positive Rotavirus Ag, EIA.  Baby was seen at the Emergency room because of the severity of symptoms, Was treated with fluids and continued breastfeeding.
pt recvd vax; fever began noc after vax;to peds 22nov94 at 12 noon;fever 104, irritable, pale,seemed to exp pain w/ mvt;MD did fuo w/u & all neg;gave atb, pt returned 23nov94 & had no fever;oth sxs resolving; no further meds given;
Headaches, joint pain and fatigue. Headaches and joint pain continued and increased after second vaccine. My BP which had always been controlled was 190/118 and I went to ED in Hypertensive crisis. Added more medication Norvasc. BP remains high 170/100 and I continue to have headaches.
Mom calls HD and reports that pt's left arm at injection site of TD is discolored and has a few bumps, after laying out in the sun. Recommended evaluation by MD. On 6/15/00, left message for her to follow-up at Health Dept.
Approximately 8-9 weeks ago I receive my first Moderna shot, then 14-16 days later I suffered the following side affects: Difficult in breathing, temperature, chest pains, fatigue and left ankle/foot pains. Within the following week most of the upper torso problems disappeared, but the left foot pains moved to my left calf and left knee for 7-8 days, then moved up to my right shoulder, right elbow, right wrist and right hand where it resides still today 7 weeks later.   Where's your medical science now? I'm suffering due to policy ineptitude, negligence and political pressures to rush unproven clinical trials. I refuse to get a second shot or vaccine based on these painful lingering side affects.
About 4 hours after the shot, I had a pounding heartbeat (not fast, just hard 70). I also had  difficulty breathing. It passed after a couple hours. I got J&J April 7, 2021, and got COVID-19 Nov 1, 2021.
Arm soreness, fever, chills, headache, flu like symptoms, flushing, nausea , muscle soreness/fatigue, weakness
Patient hospitalized for atrial fibrillation with RVR and underwent a cardioversion within 6 weeks of receiving COVID vaccination.
Adverse Events :Chills, fever up to 100.3F, whole body ache, intense muscle soreness of upper arm of the injection site Treatment: 2 Tylenol 500 mg every 6 hours , rest - slept all day Fever gone the following day on 2/5/21
This case was reported by the grandmother of a consumer and described the occurrence of hyporesponsive reaction (unspecified) in a 4-month-old female subject who was vaccinated with (INFANRIX, GlaxoSmithKline). A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of INFANRIX (unknown). At an unspecified time after vaccination with INFANRIX, the subject experienced hyporesponsive reaction (unspecified), vomiting and lump injection site that lasted over two weeks. At the time of reporting the outcome of the events was unspecified.